Improved sleep and neurocognitive functions in a child with thalamic lesions on sodium oxybate

Neurology

Volumn 68, Issue 14, 2007, Pages 1157-1158

  Kothare, S V ^a,b   Adams, R ^a   Valencia, I ^a   Faerber, E C ^a   Grant, M L ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b ST CHRISTOPHER'S HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; ATOMOXETINE; CHLORAL HYDRATE; DIPHENHYDRAMINE; MELATONIN; METHYLPHENIDATE; MODAFINIL; OXYBATE SODIUM; STEROID; TEMAZEPAM; ZOLPIDEM;

ARTICLE; BRAIN DAMAGE; CASE REPORT; CEREBROSPINAL FLUID; CLINICAL TRIAL; COGNITION; DRUG DOSE ESCALATION; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYSOMNOGRAPHY; POSTVACCINAL ENCEPHALITIS; PRIORITY JOURNAL; SCHOOL CHILD; SLEEP DISORDER; SLEEP PATTERN; SPASTICITY;

ADJUVANTS, ANESTHESIA; BRAIN INJURIES; CHILD; COGNITION; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; SLEEP; SODIUM OXYBATE; THALAMUS;

EID: 34147097877     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000258658.00692.36     Document Type: Article

References (6)

1. Beebe DW, Wells CT, et al. Neuropsychological effects of pediatric obstructive sleep apnea. J Int Neuropsychol Soc 2004;10:962-975.
2. Fuller DE, Homfeldt CS, Kelloway JS, et al. The Xyrem risk management program. Drug Safe 2004;27:293-306.
3. International Xyrem Study Group. A double-blind placebo controlled study demonstrated sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy. J Clin Sleep Med 2005;1:391-397.
4. Scharf M, Hauck M, Stover R, McDonnald M, Berkowitz D. Effect of gamma-hydroxybutyrate on pain, fatigue, and the alpha sleep anomaly in patients with fibromyalgia. Preliminary report. J Rheumatol 1998;25:1986-1990.
5. Xie X, Morairty S, Yamanaka A, et al. Electrophysiological effects of GABA-B agonists on hypocretin/EGFP neurons in mouse hypothalamic sites. Sleep 2004;27(suppl):A30.
6. Kaupmann K, Cryan JF, Wellendorph P, et al. Specific gamma- hydroxybutyrate-binding sites but loss of pharmacological effects of gamma-hydroxybutyrate in GABA-B1 deficient mice. Eur J Neurosci 2003;18:2722-2730.